ehealth digital library

Digital library of
the Tanzania
health
community

Medication Exposure During Pregnancy: A Pilot Pharmacovigilance System Using Health and Demographic Surveillance Platform.

Mosha, D., Mazuguni, F., Mrema, S., Abdulla, S. and Genton, B. (2014) Medication Exposure During Pregnancy: A Pilot Pharmacovigilance System Using Health and Demographic Surveillance Platform. BMC pregnancy and childbirth, 14 (1). p. 322. ISSN 1471-2393

[img]
Preview
PDF
Dominic_Mosha.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (95kB)

Abstract

There is limited safety information on most drugs used during pregnancy. This is especially true for medication against tropical diseases because pharmacovigilance systems are not much developed in these settings. The aim of the present study was to demonstrate feasibility of using Health and Demographic Surveillance System (HDSS) as a platform to monitor drug safety in pregnancy. Pregnant women with gestational age below 20 weeks were recruited from Reproductive and Child Health (RCH) clinics or from monthly house visits carried out for the HDSS. A structured questionnaire was used to interview pregnant women. Participants were followed on monthly basis to record any new drug used as well as pregnancy outcome. 1089 pregnant women were recruited; 994 (91.3%) completed the follow-up until delivery. 98% women reported to have taken at least one medication during pregnancy, mainly those used in antenatal programmes. Other most reported drugs were analgesics (24%), antibiotics (17%), and antimalarial (15%), excluding IPTp. Artemether-lumefantrine (AL) was the most used antimalarial for treating illness by nearly 3/4 compared to other groups of malaria drugs. Overall, antimalarial and antibiotic exposures in pregnancy were not significantly associated with adverse pregnancy outcome. Iron and folic acid supplementation were associated with decreased risk of miscarriage/stillbirth (OR 0.1; 0.08 - 0.3). Almost all women were exposed to medication during pregnancy. Exposure to iron and folic acid had a beneficial effect on pregnancy outcome. HDSS proved to be a useful platform to establish a reliable pharmacovigilance system in resource-limited countries. Widening drug safety information is essential to facilitate evidence based risk-benefit decision for treatment during pregnancy, a major challenge with newly marketed medicines.

Item Type: Article
Keywords: Pregnancy, Pharmacovigilance, Reproductive and Child Health, Pregnant women, drug, gestation
Subjects: Maternal & Neonatal Health > Antenatal care
Divisions: Ifakara Health Institute > Health Systems
Depositing User: Mr Joseph Madata
Date Deposited: 22 Sep 2014 08:01
Last Modified: 22 Sep 2014 08:01
URI: http://ihi.eprints.org/id/eprint/2887

Actions (login required)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics